Bayer (ETR:BAYN) led a $40 million Series B round for glucose monitor maker One Drop, licensed its platform for treating conditions beyond diabetes and put its pharma president on the One Drop board.

New York City-based One Drop developed a compact blood glucose monitor, pairing it with an app designed to provide behavioral cues and one-on-one coaching. The system integrates with the Apple (NSDQ:AAPL) HealthKit, CareKit, Health Records and Siri Shortcuts and the Apple Watch (Apple stores began carrying the One Drop system in June); the Google Fit offering for Android and with Fitbit and Dexcom offerings via iPhone or Android, the company said.

Get the full story at our sister site, Drug Delivery Business News